Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Maze Therapeutics (MAZE) Operating Margin (2024)

Maze Therapeutics has reported Operating Margin over the past 1 years, most recently at 969.16% for Q3 2024.

  • Quarterly Operating Margin changed N/A to 969.16% in Q3 2024 from the year-ago period, while the trailing twelve-month figure was 5033.2% through Jun 2025, changed N/A year-over-year, with the annual reading at 34.38% for FY2024, N/A changed from the prior year.
  • Operating Margin was 969.16% for Q3 2024 at Maze Therapeutics, down from 930.37% in the prior quarter.
  • Over five years, Operating Margin peaked at 930.37% in Q2 2024 and troughed at 969.16% in Q3 2024.